Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primary vs Secondary Prophylaxis with Pegfilgrastim in Elderly Cancer Patients
NCT00277160Phase 4Completed
- Sponsor
- Amgen
- Start
- Jun 2002
- Primary completion
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of pegfilgrastim in neutropenia, sponsored by Amgen. Started Jun 2002; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00277160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277160.